Profile
DBVT VRTX REGN SGEN ARGX ALNY
Company Name DBV Technologies S.A. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $92.25M $130.72B $68.52B $43.15B $35.80B $35.25B
Employees 0.11K 6.10K 15.11K 3.26K 1.60K 2.23K
CEO Mr. Daniel Tassé Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
DBVT VRTX REGN SGEN ARGX ALNY
Quant Rating Score 1 2 4 3 3 1
Quant Rating Strong Sell Sell Buy Neutral Neutral Strong Sell
Trading
DBVT VRTX REGN SGEN ARGX ALNY
Last Close $6.2 $492.69 $637.36 $228.74 $589.15 $268.46
High 52 $6.2 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.47 $392.81 $634.14 $228.74 $356.01 $143.31
Price vs. 52 Week High 0 % -4.65 % -46.96 % 0 % -12.3 % -9.53 %
Price vs. 52 Week Low 1219.15 % 25.43 % 0.51 % 0 % 65.49 % 87.33 %
Total Return
DBVT VRTX REGN SGEN ARGX ALNY
1 Month Return 56.57 % 1.94 % -6.98 % 0 % -5.38 % 10.12 %
3 Month Return 100.65 % 22.35 % -10.52 % 0 % -4.2 % 14.09 %
6 Month Return 749.32 % 4.88 % -39.12 % 0 % 7.65 % -2.75 %
9 Month Return 657.39 % 4.55 % -39.7 % 0 % 35.68 % 10.33 %
YTD Return 100.65 % 22.35 % -10.52 % 0 % -4.2 % 14.09 %
1 Year Return 727.66 % 17.87 % -33.78 % 0 % 49.64 % 79.63 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DBVT VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.14 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -37.62 % -1.65 % 5.37 % -2.27 % -44.32 % -0.24 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Profitability
DBVT VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 100 % 86.09 % 84.47 % 72.37 % 46.33 % 85.62 %
Return on Assets TTM -109.71 % -2.38 % 11.69 % -11.76 % 13.45 % -6.56 %
Return on Equity TTM -104.46 % -3.28 % 14.77 % -16.53 % 16.83 % 905.33 %
Return on Capital Employed TTM -168.4 % -1.3 % 10.89 % -16.87 % -0.31 % -5.79 %
Net Income Per EBT TTM 100.04 % -215.53 % 92.32 % 100.55 % 25990.14 % 73.71 %
EBT Per Ebit TTM 97.51 % -100.69 % 118.85 % 94.01 % -18.79 % 213.34 %
EBIT Per Revenue TTM -914.52 % -2.24 % 28.32 % -36.09 % -0.77 % -7.87 %
Cash Flow To Debt Ratio TTM -1304.77 % -28.16 % 222.76 % -185.98 % -201.37 % -0.64 %
Receivables Turnover TTM 0.57 6.84 2.29 1.98 2.46 5.55
Payables Turnover TTM - 3.71 2.79 1.54 1.83 3.66
Inventory Turnover TTM - 1.27 0.71 0.65 2.93 4.12
Fixed Asset Turnover TTM 60.32 % 425.82 % 308.76 % 256.83 % 4929.48 % 323.99 %
Asset Turnover TTM 12.3 % 48.84 % 37.61 % 34.46 % 35.83 % 53.02 %
Operating Cash Flow Per Share TTM -1.1 -1.91 41.08 -1.12 -1.07 -0.06
Free Cash Flow Per Share TTM -1.13 -3.07 33.43 -1.62 -1.09 -0.33
Cash Per Share TTM 48.29 % 2375.11 % 16647.4 % 657.5 % 4597.04 % 2095.42 %
Operating Cash Flow Sales Ratio TTM -925.53 % -4.48 % 31.13 % -16.85 % -3.54 % -0.37 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.66 % 160.43 % 81.38 % 144.14 % 102.26 % 512.38 %
Cash Flow Coverage Ratios TTM -1304.77 % -28.16 % 222.76 % -185.98 % -201.37 % -0.64 %
Price To Free Cash Flows Ratio TTM -0.8 -165.4 19.05 -141.85 -470.35 -827.74
Price To Operating Cash Flows Ratio TTM -0.77 -266.09 15.51 -203.89 -561.61 -4192.79
Price Cash Flow Ratio TTM -0.77 -266.09 15.51 -203.89 -561.61 -4192.79
Income Statement (TTM)
DBVT VRTX REGN SGEN ARGX ALNY
Revenue $0.02B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $0.02B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.09B $0.49B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.07B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -0.71 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
DBVT VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.04B $0.03B $0B
Total Liabilities $0.04B $6.12B $8.41B $0.87B $0.68B $4.17B
Total Equity $0.14B $16.41B $29.35B $2.8B $5.31B $0.07B
Total Investments $0B $6.65B $6.52B $1.42B $1.82B $1.73B
Total Debt $0.01B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.18B $22.53B $37.76B $3.67B $5.99B $4.24B
Cash Flow Statement (TTM)
DBVT VRTX REGN SGEN ARGX ALNY
Net Income $-0.07B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.08B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 21.65
ABCL AbCellera Biologics Inc. 2.31
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.97
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.19
ABPWW 0.03
ABSI Absci Corporation 2.7
ABUS Arbutus Biopharma Corporation 3.5
ABVC ABVC BioPharma, Inc. 0.86
ABVX Abivax SA American Depositary Shares 6.43
ACAD ACADIA Pharmaceuticals Inc. 17.07
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8302
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.78
ACIU AC Immune SA 1.98
ACLX Arcellx, Inc. 67.96
ETFs With Exposure to DBVT
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.00208 130.29
AIIQ AI Powered International Equity ETF 0.42 24.58
Unlock